Will Prolyl Hydroxylase Inhibitors Supplant Erythropoiesis-Stimulating Agents and IV Iron in the Treatment of Chemotherapy-Induced Anemia?
Authors: George M. Rodgers, Jeffrey A. Gilreath
Published: 2024-10-01
DOI:
10.1200/jco-24-01694
Source:
Full article
Abstract
No abstract found.